← SynDRA
TEGOBUVIR
SynDRA canonical compound SYN0028799 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Mechanism of action | HCV inhibitor | protease inhibitor |
All known targets
Mechanisms of action (all sources)
- HCV inhibitor
- protease inhibitor
- Inhibitor
Cross-references
Synonyms
- GS-333126
- GS-9190
- UNII-5NOK5X389M
- 5-((6-(2,4-bis(Trifluoromethyl)phenyl)pyridazin-3-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine
- 5NOK5X389M
- GS 9190
- GS 333126
- W-204340
- 5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-;5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-
- Tegobuvir [USAN:INN]
- Tegobuvir (USAN/INN)
- SCHEMBL496778
- CHEMBL1957287
- DTXSID80142917
- tegobuvirum
- RefChem:932660
- DTXCID8065408
- MFCD18251457
- C25H14F7N5
- Tegobuvir [INN]
- TEGOBUVIR [USAN]
- TEGOBUVIR [WHO-DD]
- orb1307687
- SCHEMBL29632593
- XBEQSQDCBSKCHJ-UHFFFAOYSA-N
- BDBM50461671
- EX-A11183
- AKOS015949531
- CS-0672
- SB16972
- NCGC00378881-01
- AS-74871
- HY-10544
- DB-349549
- NS00073275
- Tegobuvir (GS-9190; GS 333126)?
- D09971
- T17029
Look up TEGOBUVIR in the interactive SynDRA portal →